<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for SB 105          </title>
<shortdesc>APRN FULL PRACTICE AUTHORITY</shortdesc>
<sponsor>
<sponsorhead1>Senate Sponsors</sponsorhead1><sponsors>Sen. Sara Feigenholtz and Rachelle Crowe</sponsors>
<sponsorhead2>House Sponsors</sponsorhead2><altsponsors>(Rep. Anna Moeller)</altsponsors>
</sponsor>
<lastaction>
<statusdate>7/9/2021</statusdate><chamber>Senate</chamber><action>Public Act . . . . . . . . . 102-0075</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>225 ILCS 65/65-43</reference><aliasreference></aliasreference><SynopsisText>Amends the Nurse Practice Act. Removes language requiring that a collaborating physician attest to the completion of the clinical experience required for an advanced practice registered nurse to practice without a written collaborative agreement. Removes a provision that includes prescribing benzodiazepines or Schedule II narcotic drugs only in a consultation relationship with a physician within the scope of practice of an advanced practice registered nurse with full practice authority.</SynopsisText><synopsistitle>Senate Committee Amendment No. 1</synopsistitle>
<SynopsisText>Replaces everything after the enacting clause. Reinserts the provisions of the introduced bill with the following changes: In a provision concerning clinical experience for an advanced practice registered nurse, provides that completion of the clinical experience must be attested to by the collaborating physician or physicians or employer (rather than the collaborating physician or physicians) and the advanced practice registered nurse. Provides that if the collaborating physician or physicians or employer is unable to attest to the completion of the clinical experience, the Department of Financial and Professional Regulation may accept other evidence of clinical experience as established by rule. Restores language concerning prescribing benzodiazepines or Schedule II narcotic drugs that was stricken in the introduced bill.</SynopsisText></synopsis>
<actions>
<statusdate>2/3/2021</statusdate><chamber>Senate</chamber><action>Filed with Secretary by Sen. Sara Feigenholtz</action>
<statusdate>2/3/2021</statusdate><chamber>Senate</chamber><action>First Reading</action>
<statusdate>2/3/2021</statusdate><chamber>Senate</chamber><action>Referred to Assignments</action>
<statusdate>2/17/2021</statusdate><chamber>Senate</chamber><action>Assigned to Licensed Activities</action>
<statusdate>3/17/2021</statusdate><chamber>Senate</chamber><action>Postponed - Licensed Activities</action>
<statusdate>3/24/2021</statusdate><chamber>Senate</chamber><action>Postponed - Licensed Activities</action>
<statusdate>4/8/2021</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Filed with Secretary by Sen. Sara Feigenholtz</action>
<statusdate>4/8/2021</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Referred to Assignments</action>
<statusdate>4/13/2021</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Assignments Refers to Licensed Activities</action>
<statusdate>4/14/2021</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Adopted</action>
<statusdate>4/15/2021</statusdate><chamber>Senate</chamber><action>Do Pass as Amended Licensed Activities;  008-000-000</action>
<statusdate>4/15/2021</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of 2nd Reading April 20, 2021</action>
<statusdate>4/21/2021</statusdate><chamber>Senate</chamber><action>Second Reading</action>
<statusdate>4/21/2021</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of 3rd Reading April 22, 2021</action>
<statusdate>4/22/2021</statusdate><chamber>Senate</chamber><action>Third Reading - Passed; 053-000-000</action>
<statusdate>4/22/2021</statusdate><chamber>House</chamber><action>Arrived in House</action>
<statusdate>4/22/2021</statusdate><chamber>House</chamber><action>Chief House Sponsor Rep. Anna Moeller</action>
<statusdate>4/23/2021</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>4/23/2021</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>4/23/2021</statusdate><chamber>Senate</chamber><action>Added as Co-Sponsor Sen. Rachelle Crowe</action>
<statusdate>5/4/2021</statusdate><chamber>House</chamber><action>Assigned to Health Care Licenses Committee</action>
<statusdate>5/12/2021</statusdate><chamber>House</chamber><action>Do Pass / Consent Calendar Health Care Licenses Committee;  008-000-000</action>
<statusdate>5/12/2021</statusdate><chamber>House</chamber><action>Placed on Calendar 2nd Reading - Consent Calendar</action>
<statusdate>5/13/2021</statusdate><chamber>House</chamber><action>Second Reading - Consent Calendar</action>
<statusdate>5/13/2021</statusdate><chamber>House</chamber><action>Held on Calendar Order of Second Reading - Consent Calendar</action>
<statusdate>5/14/2021</statusdate><chamber>House</chamber><action>Placed on Calendar Order of 3rd Reading - Consent Calendar</action>
<statusdate>5/21/2021</statusdate><chamber>House</chamber><action>Third Reading - Consent Calendar - First Day</action>
<statusdate>5/26/2021</statusdate><chamber>House</chamber><action>Third Reading - Consent Calendar -  Passed 112-000-000</action>
<statusdate>5/26/2021</statusdate><chamber>Senate</chamber><action>Passed Both Houses</action>
<statusdate>6/24/2021</statusdate><chamber>Senate</chamber><action>Sent to the Governor</action>
<statusdate>7/9/2021</statusdate><chamber>Senate</chamber><action>Governor Approved</action>
<statusdate>7/9/2021</statusdate><chamber>Senate</chamber><action>Effective Date January 1, 2022</action>
<statusdate>7/9/2021</statusdate><chamber>Senate</chamber><action>Public Act . . . . . . . . . 102-0075</action>
</actions>
</xml>

